Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report

about

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report

Item

http://www.wikidata.org/entity/Q38859330

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pancreas-protective effect of ...... oneymoon period: a case report

@en

type

Item

label

Pancreas-protective effect of ...... oneymoon period: a case report

@en

prefLabel

Pancreas-protective effect of ...... oneymoon period: a case report

@en

P1476

Pancreas-protective effect of ...... oneymoon period: a case report

@en

P2093

Akira Kurozumi

http://www.w3.org/2001/XMLSchema#string

Keiichi Torimoto

http://www.w3.org/2001/XMLSchema#string

Maiko Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Satoshi Kubo

http://www.w3.org/2001/XMLSchema#string

Shingo Nakayamada

http://www.w3.org/2001/XMLSchema#string

Tadashi Arao

http://www.w3.org/2001/XMLSchema#string

Yoshiya Tanaka

http://www.w3.org/2001/XMLSchema#string

Yosuke Okada

http://www.w3.org/2001/XMLSchema#string

Yusuke Miyazaki

http://www.w3.org/2001/XMLSchema#string

P2860

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis

STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.

Therapeutic targeting of Syk in autoimmune diabetes

B-cell targeting in rheumatoid arthritis and other autoimmune diseases.

Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes.

Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.

Protein tyrosine kinase, syk: a key player in phagocytic cells.

B-lymphocyte depletion with rituximab and β-cell function: two-year results

P304

160020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EDM-16-0020

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27252867

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

Aizkuņģa dziedzeris

P932

4870497

http://www.w3.org/2001/XMLSchema#string